An open-label Phase 3 study of S-474474 in patients with essential hypertension - Evaluation of the safety and efficacy of long term use
Phase 3
- Conditions
- Hypertension
- Registration Number
- JPRN-jRCT2080221437
- Lead Sponsor
- SHIONOGI & CO., LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Patients with essential hypertension who meet the following criteria:
Untreated patients whose seated systolic blood pressure is not less than 160 mmHg, or seated diastolic blood pressure is not less than 100 mmHg, and systolic blood pressure is lower than 180 mmHg, and diastolic blood pressure is lower than 110 mmHg, etc.
Exclusion Criteria
Patients with renal, hepatic or heart disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Adverse events and adverse drug reactions, etc
- Secondary Outcome Measures
Name Time Method Change in trough seated systolic and diastolic blood pressure